Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deciphera Pharmaceuticals IncfiledCriticalDeciphera Pharmaceuticals Inc
Publication of AR122301A1publicationCriticalpatent/AR122301A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente divulgación se refiere a métodos para tratar a un sujeto que lo necesita por tumores del estroma gastrointestinal, y comprende administrar al sujeto una cantidad terapéuticamente eficaz de ripretinib o una sal farmacéuticamente aceptable de este.The present disclosure relates to methods of treating a subject in need thereof for gastrointestinal stromal tumors, and comprises administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.
ARP200102289A2019-08-122020-08-12
METHODS TO TREAT GASTROINTESTINAL STROMAL TUMORS
AR122301A1
(en)
Use of a composition comprising a) a compound of defined formula (ia) or a salt thereof and b) a pharmaceutically acceptable carrier or excipient to prepare a medicament useful for treating an allergic condition in a mammal.